Home > Drug Delivery Devices Market Outlook in Republic of Korea to 2016 - Inhalation Systems, Infusion Systems and Others (Table of Contents)

Drug Delivery Devices Market Outlook in Republic of Korea to 2016 - Inhalation Systems, Infusion Systems and Others

GlobalData
August 25, 2010
74 Pages - SKU: GBDT2809240

Abstract Table of Contents Search inside this report Related Reports Detailed Contents

1 Table of Contents: 1.1 List of Tables; 1.2 List of Figures
2 Introduction: 2.1 What is This Report About?
3 Drug Delivery Devices In Republic of Korea: 3.1 Drug Delivery Devices, Market Segmentation; 3.2 Drug Delivery Devices, Republic of Korea, Overall Revenue ($m), 2002-2016; 3.3 Drug Delivery Devices Market, Republic of Korea, Revenue Mix ($m), 2009; 3.4 Drug Delivery Devices Market, Republic of Korea, Category Contribution (%), 2009; 3.5 Drug Delivery Devices, Republic of Korea, Category Volume (Units), 2002-2016; 3.6 Drug Delivery Devices, Republic of Korea, Company Share (2008-2009)
4 Infusion Systems In Republic of Korea: 4.1 Infusion Systems, Market Segmentation; 4.2 Infusion Systems Market, Republic of Korea, Revenue Mix ($m), 2009; 4.3 Infusion Systems Market, Republic of Korea, Segment Contribution (%), 2009; 4.4 Infusion Systems Overall Revenue (2002-2016); 4.5 Infusion Systems Overall Volume (2002-2016); 4.6 Infusion Systems Average Price (2002-2016); 4.7 Infusion Systems Distribution Share (2008-2009); 4.8 Infusion Systems, Republic of Korea, Company Share (2008-2009)
5 Inhalation Systems In Republic of Korea: 5.1 Inhalation Systems, Market Segmentation; 5.2 Inhalation Systems Market, Republic of Korea, Revenue Mix ($m), 2009; 5.3 Inhalation Systems Market, Republic of Korea, Segment Contribution (%), 2009; 5.4 Inhalation Systems Overall Revenue (2002-2016); 5.5 Inhalation Systems Overall Volume (2002-2016); 5.6 Inhalation Systems Average Price (2002-2016); 5.7 Inhalation Systems Distribution Share (2008-2009); 5.8 Inhalation Systems, Republic of Korea, Company Share (2008-2009)
6 Overview of Key Companies in Republic of Korea Drug Delivery Devices Market: 6.1 GlaxoSmithKline plc; 6.2 AstraZeneca PLC; 6.3 Baxter International Inc.; 6.4 Boehringer Ingelheim GmbH; 6.5 Fresenius Kabi AG; 6.6 3M Health Care; 6.7 Smiths Medical; 6.8 B. Braun Melsungen AG; 6.9 Cardinal Health, Inc.; 6.10 Hospira, Inc.; 6.11 Terumo Corporation; 6.12 Novartis Medical Nutrition; 6.13 JMS CO., LTD.; 6.14 NIPRO CORPORATION; 6.15 CareFusion Corporation
7 Drug Delivery Devices Market Pipeline Products
8 Appendix: 8.1 Definitions of Markets Covered in the Report; 8.2 Research Methodology; 8.3 Secondary Research; 8.4 Primary Research; 8.5 Models; 8.6 Forecasts; 8.7 Expert Panels; 8.8 GlobalData Consulting; 8.9 Currency Conversion; 8.10 Contact Us; 8.11 Disclaimer
1.1 List of Tables: Table 1: Drug Delivery Devices, Republic of Korea, Overall Revenue ($m), 2002-2016; Table 2: Drug Delivery Devices Market, Republic of Korea, Category Contribution (%), 2009; Table 3: Drug Delivery Devices, Republic of Korea, Cross-Segment Analysis, 2002-2016; Table 4: Drug Delivery Devices, Republic of Korea, Overall Revenue ($m), Historic, 2002-2009; Table 5: Drug Delivery Devices, Republic of Korea, Overall Revenue ($m), Forecast, 2009-2016; Table 6: Drug Delivery Devices, Republic of Korea, Category Volume (Units), 2002-2016; Table 7: Drug Delivery Devices, Republic of Korea, Category Volume (Units), Historic, 2002-2009; Table 8: Drug Delivery Devices, Republic of Korea, Category Volume (Units), Forecast, 2009-2016; Table 9: Drug Delivery Devices, Republic of Korea, Company Share by Revenue ($m), 2008-2009; Table 10: Infusion Systems Market, Republic of Korea, Segment Contribution (%), 2009; Table 11: Infusion Systems, Republic of Korea, Revenue ($m) by Segment, Historic, 2002-2009; Table 12: Infusion Systems, Republic of Korea, Revenue ($m) by Segment, Forecast, 2009-2016; Table 13: Infusion Systems, Republic of Korea, Volume (Units) by Segment, Historic, 2002-2009; Table 14: Infusion Systems, Republic of Korea, Volume (Units) by Segment, Forecast, 2009-2016; Table 15: Infusion Systems, Republic of Korea, Average Price ($), Historic, 2002-2009; Table 16: Infusion Systems, Republic of Korea, Average Price ($), Forecast, 2009-2016; Table 17: Infusion Systems, Republic of Korea, Distribution Share by Revenue ($m), 2008-2009; Table 18: Infusion Systems, Republic of Korea, Company Share by Revenue ($m), 2008-2009; Table 19: Inhalation Systems Market, Republic of Korea, Segment Contribution (%), 2009; Table 20: Inhalation Systems, Republic of Korea, Revenue ($m) by Segment, Historic, 2002-2009; Table 21: Inhalation Systems, Republic of Korea, Revenue ($m) by Segment, Forecast, 2009-2016; Table 22: Inhalation Systems, Republic of Korea, Volume (Units) by Segment, Historic, 2002-2009; Table 23: Inhalation Systems, Republic of Korea, Volume (Units) by Segment, Forecast, 2009-2016; Table 24: Inhalation Systems, Republic of Korea, Average Price ($), Historic, 2002-2009; Table 25: Inhalation Systems, Republic of Korea, Average Price ($), Forecast, 2009-2016; Table 26: Inhalation Systems, Republic of Korea, Distribution Share by Revenue ($m), 2008-2009; Table 27: Inhalation Systems, Republic of Korea, Company Share by Revenue ($m), 2008-2009; Table 28: Drug Delivery Devices Market Pipeline Products; Table 29: USD to Local Currency, Republic of Korea, Average Actual Rate 2002-2009
1.2 List of Figures: Figure 1: Drug Delivery Devices, Market Segmentation; Figure 2: Drug Delivery Devices, Republic of Korea, Overall Revenue ($m), 2002-2016; Figure 3: Drug Delivery Devices Market, Republic of Korea, Revenue Mix ($m), 2009; Figure 4: Drug Delivery Devices Market, Republic of Korea, Category Contribution (%), 2009; Figure 5: Drug Delivery Devices Market, Republic of Korea, Cross-Segment Analysis, 2002-2016; Figure 6: Drug Delivery Devices, Republic of Korea, Overall Revenue ($m), Historic, 2002-2009; Figure 7: Drug Delivery Devices, Republic of Korea, Overall Revenue ($m), Forecast, 2009-2016; Figure 8: Drug Delivery Devices, Republic of Korea, Category Volume (Units), 2002-2016; Figure 9: Drug Delivery Devices, Republic of Korea, Category Volume (Units), Historic, 2002-2009; Figure 10: Drug Delivery Devices, Republic of Korea, Category Volume (Units), Forecast, 2009-2016; Figure 11: Drug Delivery Devices, Republic of Korea, Company Share (%), 2009; Figure 12: Infusion Systems, Market Segmentation; Figure 13: Infusion Systems Market, Republic of Korea, Revenue Mix ($m), 2009; Figure 14: Infusion Systems Market, Republic of Korea, Segment Contribution (%), 2009; Figure 15: Infusion Systems, Republic of Korea, Revenue ($m) by Segment, Historic, 2002-2009; Figure 16: Infusion Systems, Republic of Korea, Revenue ($m) by Segment, Forecast, 2009-2016; Figure 17: Infusion Systems, Republic of Korea, Volume (Units) by Segment, Historic, 2002-2009; Figure 18: Infusion Systems, Republic of Korea, Volume (Units) by Segment, Forecast, 2009-2016; Figure 19: Infusion Systems, Republic of Korea, Company Share (%), 2009; Figure 20: Inhalation Systems, Market Segmentation; Figure 21: Inhalation Systems Market, Republic of Korea, Revenue Mix ($m), 2009; Figure 22: Inhalation Systems Market, Republic of Korea, Segment Contribution (%), 2009; Figure 23: Inhalation Systems, Republic of Korea, Revenue ($m) by Segment, Historic, 2002-2009; Figure 24: Inhalation Systems, Republic of Korea, Revenue ($m) by Segment, Forecast, 2009-2016; Figure 25: Inhalation Systems, Republic of Korea, Volume (Units) by Segment, Historic, 2002-2009; Figure 26: Inhalation Systems, Republic of Korea, Volume (Units) by Segment, Forecast, 2009-2016; Figure 27: Inhalation Systems, Republic of Korea, Company Share (%), 2009; Figure 28: GlaxoSmithKline plc, Company Share (%),Republic of Korea Drug Delivery Devices Market, 2009; Figure 29: AstraZeneca PLC, Company Share (%),Republic of Korea Drug Delivery Devices Market, 2009; Figure 30: Baxter International Inc., Company Share (%),Republic of Korea Drug Delivery Devices Market, 2009; Figure 31: Boehringer Ingelheim GmbH, Company Share (%),Republic of Korea Drug Delivery Devices Market, 2009; Figure 32: Fresenius Kabi AG, Company Share (%),Republic of Korea Drug Delivery Devices Market, 2009; Figure 33: 3M Health Care, Company Share (%),Republic of Korea Drug Delivery Devices Market, 2009

Research assistance

We can help you find what you need. Call us or write us:

US: 800.298.5699

Int'l: +1.240.747.3093

Need help in your search?

Related Markets

Drug Delivery Reports

Share this report

Email a colleague

Other tasks

Join Alert Me now!

Receive bi-weekly email alerts on new market research

Sign up today!